Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4441 to 4455 of 7679 results

  1. What is the most clinically and cost-effective follow‑up protocol for people with prostate cancer who have had radical treatment, with specific regard to risk stratification, duration of follow‑up, frequency of follow‑up appointments, the type of examination or blood tests, and the roles of primary and secondary care in follow‑up?

    Recommendation ID NG131/2 Question What is the most clinically and cost-effective follow‑up protocol for people with prostate cancer who

    Research recommendation
    Published
    25 October 2019

  2. Follow-up after treatment with curative intent:- Is the routine use of CT and tumour markers effective in detecting recurrent disease suitable for radical treatment in asymptomatic people who have had treatment for oesophago-gastric cancer with curative intent?

    Recommendation ID NG83/5 Question Follow-up after treatment with curative intent:- Is the routine use of CT and tumour markers effective

    Research recommendation
    Published
    13 November 2018

  3. What is the most suitable surveillance protocol (including the role of digital rectal examination [DRE] and prostate-specific antigen [PSA] measures) for people for whom active surveillance is appropriate, as assessed by multiparametric MRI and biopsy, when there are no clinical concerns during follow‑up?

    Recommendation ID NG131/1 Question What is the most suitable surveillance protocol (including the role of digital rectal examination [DRE]

    Research recommendation
    Published
    25 October 2019

  4. Follow-up:- What is the optimal method, frequency and duration of follow-up for people who are disease-free after treatment for CUADT?

    Recommendation ID NG36/5 Question Follow-up:- What is the optimal method, frequency and duration of follow-up for people who are disease-free

    Research recommendation
    Published
    6 April 2016

  5. Managing anaemia: For adults, children and young people with CKD and anaemia, what is the diagnostic accuracy of eGFR thresholds of 60, 45, and 30 ml/min/1.73 m2 for determining whether the anaemia is due to CKD?

    Recommendation ID NG203/13 Question Managing anaemia: For adults, children and young people with CKD and anaemia, what is the diagnostic

    Research recommendation
    Published
    30 September 2021

  6. Managing anaemia: For adults, children and young people with CKD and anaemia who are on peritoneal dialysis, what amount of intravenous (IV) iron is most clinically and cost effective in managing anaemia and its associated outcomes (including quality of life)?

    Recommendation ID NG203/14 Question Managing anaemia: For adults, children and young people with CKD and anaemia who are on peritoneal

    Research recommendation
    Published
    30 September 2021

  7. For adults who want to stop smoking, what is the effectiveness and cost effectiveness of Allen Carr's Easyway programme delivered in formats other than in-person group seminars (for example online or using the self-help book) compared with other methods of smoking cessation?

    Recommendation ID NG209/14 Question For adults who want to stop smoking, what is the effectiveness and cost effectiveness of Allen Carr's

    Research recommendation
    Published
    7 September 2022

  8. Endoscopic treatments: For adults with Barrett's oesophagus with dysplasia, what is the effectiveness of different endoscopic ablation techniques alone or in combination with endoscopic resection?

    Recommendation ID NG231/04A Question Endoscopic treatments: For adults with Barrett's oesophagus with dysplasia, what is the effectiveness

    Research recommendation
    Published
    9 March 2023

  9. Endoscopic treatments: For adults with stage 1 oesophageal adenocarcinoma, what is the effectiveness of different endoscopic ablation techniques alone or in combination with endoscopic resection?

    Recommendation ID NG231/04B Question Endoscopic treatments: For adults with stage 1 oesophageal adenocarcinoma, what is the effectiveness

    Research recommendation
    Published
    9 March 2023

  10. Increasing the dose of ICS within a personalised self-management programme for children and young people - For children and young people with asthma that is managed in primary care, is there an advantage to increasing the inhaled corticosteroid (ICS) dose when asthma control has deteriorated compared with using the usual dose in a self-management programme?

    Recommendation ID NG80/11 Question Increasing the dose of ICS within a personalised self-management programme for children and young people

    Research recommendation
    Published
    6 August 2021

  11. Duration of thyroid stimulating hormone suppression: For people with differentiated thyroid cancer who have had surgery and radioactive iodine (RAI), what is the optimal duration of thyroid stimulating hormone suppression?

    Recommendation ID NG230/04 Question Duration of thyroid stimulating hormone suppression: For people with differentiated thyroid cancer

    Research recommendation
    Published
    6 January 2023

  12. Renin–angiotensin–aldosterone system antagonists: For people aged over 75 years with CKD, what is the clinical effectiveness of renin–angiotensin–aldosterone system (RAAS) antagonists? [2014]

    Recommendation ID NG203/20 Question Renin–angiotensin–aldosterone system antagonists: For people aged over 75 years with CKD, what is the

    Research recommendation
    Published
    30 September 2021

  13. Imaging for further staging: For people with differentiated thyroid cancer who have initial ultrasound evidence of extensive local spread (T2N1), what is the clinical and cost effectiveness of CT, MRI or F-18 FDG PET-CT scanning, with or without ultrasound, as part of a further staging strategy?

    Recommendation ID NG230/07 Question Imaging for further staging: For people with differentiated thyroid cancer who have initial ultrasound

    Research recommendation
    Published
    6 January 2023

  14. Multicomponent intervention: For people in long-term care, is a multicomponent non-pharmacological intervention more clinically and cost effective than usual care in preventing the development of delirium?

    Recommendation ID CG103/04 Question Multicomponent intervention: For people in long-term care, is a multicomponent non-pharmacological

    Research recommendation
    Published
    3 February 2023

  15. Further research on implanting a baroreceptor stimulation device for resistant hypertension should document patient selection in detail and should specify the devices and techniques used, and any adjunctive therapies. It should describe the changes in blood pressure that are considered to result from baroreceptor stimulation, and those that might be caused by other factors. Outcomes should include the duration of effect of baroreceptor stimulation; device durability; and the complications of hypertension, such as myocardial infarction and stroke.

    Recommendation ID IPG533/1 Question Further research on implanting a baroreceptor stimulation device for resistant hypertension should

    Research recommendation
    Published
    9 December 2015